Outlook Therapeutics (41O.F) Q2 2025 Earnings

15MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.94
-0.74
-0.55
-0.36

Details

Expected EPS
-0.4850530956
Actual EPS
-0.357432
Surprise EPS
0.13
Surprise Percent
+26.31%

Description

Outlook Therapeutics (41O.F) has reported earnings of -0.357432 per share for Q2 2025.

0 Comments

Share your thoughts